Italian Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Results

0 new

High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

2 companies

Philogen

Market Cap: €903.4m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

PHIL

€22.40

-0.9%

7.2%

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €195.4m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

€7.98

-1.0%

-8.1%